Skip to Content

Estradiol / progesterone Pregnancy and Breastfeeding Warnings

Estradiol / progesterone is also known as: Bijuva

Medically reviewed by Drugs.com. Last updated on Feb 18, 2019.

Estradiol / progesterone Pregnancy Warnings

Epidemiologic studies and meta-analyses have not shown exposure to combined hormonal contraceptives (estrogen and progestins) increases the risk of genital or non-genital birth defects with exposure before conception or during pregnancy. This drug is not indicated for use in females of reproductive potential. There are no controlled data in human pregnancy.

US FDA pregnancy category Not Assigned: The US FDA has amended the pregnancy labeling rule for prescription drug products to require labeling that includes a summary of risk, a discussion of the data supporting that summary, and relevant information to help health care providers make prescribing decisions and counsel women about the use of drugs during pregnancy. Pregnancy categories A, B, C, D, and X are being phased out.

This drug is not indicated for use during pregnancy

US FDA pregnancy category: Not assigned

Risk Summary: There are no data on use of this drug in pregnant women; this drug is not indicated for use in females of reproductive potential

See references

Estradiol / progesterone Breastfeeding Warnings

This drug is not indicated for use in lactating females

Excreted into human milk: Yes

See references

References for pregnancy information

  1. "Product Information. Bijuva (estradiol-progesterone)." TherapeuticsMD, Boca Raton, FL.

References for breastfeeding information

  1. "Product Information. Bijuva (estradiol-progesterone)." TherapeuticsMD, Boca Raton, FL.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide